Sarah Spencer
Investor Relations Contact at VOR BIOPHARMA INC.
Network origin in Sarah Spencer first degree
Entity | Entity type | Industry | |
---|---|---|---|
Subsidiary | Biotechnology | 21 | |
Public Company | Biotechnology | 11 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Sarah Spencer via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
Harvard Medical School | College/University | Doctorate Degree Doctorate Degree Doctorate Degree Corporate Officer/Principal | |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
OCATA THERAPEUTICS INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Medical/Nursing Services | Chairman Director/Board Member Director/Board Member | |
Yale University | College/University | Masters Business Admin Undergraduate Degree | |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
OrbiMed Advisors Private Equity
OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity (OrbiMed Advisors Private Equity) is a private equity and venture capital subsidiary of Orbimed Advisors LLC founded in 1993 by Samuel D. Isaly. The firm is headquartered in New York and it has additional offices in San Francisco, Mumbai, Shanghai, Herzliya, Hong Kong and London. | Investment Managers | Corporate Officer/Principal Corporate Officer/Principal | |
501 ACQU | Financial Conglomerates | Director/Board Member Director/Board Member | |
Enobia Pharma, Inc.
Enobia Pharma, Inc. Pharmaceuticals: MajorHealth Technology Enobia Pharma, Inc. develops therapies to treat patients with ultra-rare and life-threatening genetic metabolic bone disorders. Its lead product candidate, asfotase alfa or ENB-0040, is a treatment for hypophosphatasia—a life-threatening disease that can cause skeletal deformity, severe muscle weakness and progressive damage to vital organs. The company was founded in 1997 and is headquartered in Montreal, Canada. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
University of Colorado Boulder | College/University | Graduate Degree Doctorate Degree | |
THIRD HARMONIC BIO, INC. | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
BAVARIAN NORDIC A/S | Pharmaceuticals: Major | Corporate Officer/Principal Human Resources Officer | |
NEON THERAPEUTICS, INC. | Biotechnology | Corporate Officer/Principal Director of Finance/CFO | |
RA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Undergraduate Degree | |
Raptor Pharmaceuticals, Inc.
Raptor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Raptor Pharmaceuticals, Inc. operates as a biopharmaceutical company which develops and markets life-altering therapeutics. The company is headquartered in Novato, CA. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
BLUEPRINT MEDICINES CORPORATION | Biotechnology | Director/Board Member Director/Board Member | |
CRISPR THERAPEUTICS AG | Biotechnology | Chief Tech/Sci/R&D Officer Director/Board Member | |
ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Massachusetts Institute of Technology | College/University | Undergraduate Degree Graduate Degree | |
TRANSLATE BIO, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Tango Therapeutics Sub, Inc.
Tango Therapeutics Sub, Inc. BiotechnologyHealth Technology Tango Therapeutics, Inc. develops transformational new drugs for cancer patients. The company was founded by Alan Ashworth, Jos? Baselga, Levi Garraway, Timothy K. Lu, Antoni Ribas and William G. Kaelin, Jr. in 2017 and is headquartered in Cambridge, MA. | Biotechnology | Director of Finance/CFO Human Resources Officer | |
TAYSHA GENE THERAPIES, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Human Resources Officer | |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Corporate Officer/Principal Doctorate Degree | |
Astellas Pharma Europe Ltd.
Astellas Pharma Europe Ltd. Pharmaceuticals: MajorHealth Technology Astellas Pharma Europe Ltd. engages in the development and sale of pharmaceutical products. The company is headquartered in Addlestone, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
University of Illinois | College/University | Graduate Degree | |
Nayan Therapeutics, Inc.
Nayan Therapeutics, Inc. BiotechnologyHealth Technology Nayan Therapeutics, Inc. operates as a biotechnology company. It focuses on small molecule development for oscular disorders involving rod degeneration. The company is headquartered in Medfield, MA. | Biotechnology | Director/Board Member | |
Be Biopharma, Inc.
Be Biopharma, Inc. Miscellaneous Commercial ServicesCommercial Services Be Biopharma, Inc. develops engineered B cells as a new category of cellular medicines. The company was founded by David Steinberg, Aleks Radovic-Moreno and Lea Hachigian and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Director/Board Member | |
Ventus Therapeutics, Inc.
Ventus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ventus Therapeutics, Inc. operates as a biopharmaceutical company. It focuses in developing novel small molecule medicines that target the innate immune system to treat autoimmune diseases, inflammatory diseases and cancer. The company was founded by Hao Wu, Richard Flavell, Judy Lieberman, Thomas Tuschl, and Feng Shao and is headquartered in Montreal, Canada. | Pharmaceuticals: Major | Director/Board Member | |
Sionna Therapeutics, Inc.
Sionna Therapeutics, Inc. Medical/Nursing ServicesHealth Services Sionna Therapeutics, Inc. is a clinical-stage life sciences company located in Natick, MA. The company is dedicated to developing highly effective and differentiated treatments for cystic fibrosis (CF) by normalizing the function of CFTR, the key protein associated with disease progression in CF. Sionna is advancing a pipeline of small molecules engineered to correct the protein defects caused by ?F508, the most common mutation that affects the CFTR protein. The company has a first-in-class portfolio of programs directly targeting correction of ?F508-CFTR, the key and unique mechanism to enable full restoration of ?F508-CFTR function, and complementary programs targeting ICL4 and more. The CEO of the company is Michael Cloonan. | Medical/Nursing Services | Director/Board Member | |
Bright Peak Therapeutics AG
Bright Peak Therapeutics AG BiotechnologyHealth Technology Bright Peak Therapeutics AG engages in the development of engineered cytokines for immuno-oncology indications. The company is headquartered in Basel, Switzerland. | Biotechnology | Director/Board Member | |
ABEONA THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member | |
AEROVATE THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Santi Therapeutics, Inc.
Santi Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Santi Therapeutics, Inc. provides pharmaceutical services. The company is headquartered in Boston, MA. | Pharmaceuticals: Major | Director/Board Member | |
Bright Peak Therapeutics, Inc.
Bright Peak Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Bright Peak Therapeutics AG, Bright Peak Therapeutics, Inc. develops immunotherapies for the treatment of cancer and autoimmune diseases. The company is based in San Diego, CA. The company was founded by Vijaya R. Pattabiraman, Jeffrey Bode. The CEO is Fredrik Wiklund. | Pharmaceuticals: Major | Director/Board Member | |
PEPGEN INC. | Biotechnology | Director/Board Member | |
The University of North Carolina at Greensboro | College/University | Undergraduate Degree | |
RA Capital Management LP (Private Equity)
RA Capital Management LP (Private Equity) Investment ManagersFinance RA Capital Management LP (Private Equity) (RA Capital) is a private equity & venture capital subsidiary of RA Capital Management LP founded by Peter Kolchinsky in 2004. The firm is headquartered in Boston, MA. | Investment Managers | Private Equity Investor | |
Ventus Therapeutics U.S., Inc.
Ventus Therapeutics U.S., Inc. Medical DistributorsDistribution Services Ventus Therapeutics U.S., Inc. operates as a biotechnology company. The company is headquartered in Natick, MA. | Medical Distributors | Director/Board Member | |
AVEDRO, INC. | Medical Specialties | Director/Board Member | |
PDL BIOPHARMA, INC. | Biotechnology | Human Resources Officer | |
VISTERRA INC | Pharmaceuticals: Major | Director/Board Member | |
Aliada Therapeutics, Inc.
Aliada Therapeutics, Inc. BiotechnologyHealth Technology Aliada Therapeutics, Inc. is a neuroscience-focused company that aims to overcome the delivery hurdle in large molecule drug development. The company is based in Boston, MA. The company is advancing a generation of CNS therapeutics using its novel BBB crossing platform technology, which can efficiently transport a diverse array of therapeutic cargoes into the brain, resulting in enhanced downstream effectiveness. Aliada Therapeutics was founded by Sanjaya Singh, and the CEO is Adam Rosenberg. | Biotechnology | Director/Board Member | |
University of Wisconsin | College/University | Undergraduate Degree |
Statistics
International
United States | 45 |
Canada | 3 |
Switzerland | 3 |
Denmark | 2 |
United Kingdom | 2 |
Sectoral
Health Technology | 34 |
Consumer Services | 9 |
Finance | 5 |
Commercial Services | 3 |
Health Services | 3 |
Operational
Director/Board Member | 160 |
Corporate Officer/Principal | 72 |
Independent Dir/Board Member | 62 |
Chief Tech/Sci/R&D Officer | 29 |
Undergraduate Degree | 23 |
Most connected contacts
Insiders | |
---|---|
Joshua Resnick | 36 |
Louis Lange | 35 |
David Lubner | 19 |
Jennifer Jarrett | 18 |
Mark Goldberg | 17 |
Thomas Schuetz | 17 |
Bill Lundberg | 17 |
Scott Morrison | 16 |
Percival Barretto-Ko | 15 |
Julie Smith | 15 |
Matt Patterson | 14 |
Natalie Holles | 13 |
Bob Ang | 12 |
Suyash Prasad | 11 |
Daniella Beckman | 10 |
- Stock Market
- Insiders
- Sarah Spencer
- Company connections